Pancreatic Cancer Research

ResearcherTongji HospitalNo recent work listed

Liang Chu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9209-2181; OpenAlex author ID A5020409706. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper

Papers 2

  1. Effects of RNA binding protein QKI on pancreatic cancer ductal epithelial cells and surrounding activation fibroblasts. Co-author DOI 10.1002/jcb.28435↗
  2. RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion. First author DOI 10.1038/cddis.2017.230↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zifan Lu · 1 shared paper, 2019 · strength 0.11
  2. Zhi‐Nan Chen · 1 shared paper, 2017 · strength 0.06
  3. Yanni Xu · 1 shared paper, 2017 · strength 0.06
  4. Zongsuo Liang · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.